New possibilities in the treatment of febrile neutropenia - comfortable home treatment in a single dose

Abstract

Febrile neutropenia is a significant early complication of high-risk chemotherapy, especially in the 1st and subsequent cycles of treatment. Prolonged potency G-CSF molecules are preferred for prophylactic administration.

There is a clear trend for outpatient home applications of pegillated G-CSF subcutaneous injections 24-72 hours after chemotherapy. Podpořeno: Accord Healthcare.

Keywords

• neutropenia
• granulopoesis growth factor
• pegfilgrastim